Europe human milk fortifier market Revenue to cross US$ 150.86 million by 2030

At 9.0% CAGR, the Europe Human Milk Fortifier Market is Projected to be worth US$ 150.86 Million by 2030, says The Insight Partners

According to The Insight Partners’ research, the Europe human milk fortifier market is expected to grow from US$ 82.62 million in 2023 to US$ 150.86 million by 2030, registering a CAGR of 9.0% from 2023 to 2030. Increase in number of preterm births is the critical factor attributed to the Europe human milk fortifier market expansion.

Human milk fortifiers are recommended for preterm babies, underweight infants, and infants having nutritional deficiencies. Providing human milk fortifiers to infants that have started to suckle at the breast can be challenging for the mother and might shorten the duration of the breastfeeding period. Hence, feeding techniques such as cup feeding, supplemental nursing system (SNS), and finger feeder method are introduced to increase the use of fortifiers in infants after discharge from hospitals. Cup feeding is one of the safe fortifiers feeding but cannot be used during nursing. Supplement nursing system is another alternative for providing human milk fortifiers during breastfeeding. However, this system is difficult to handle and requires nursing experience to feed the baby. The finger feeder method enables mothers to breastfeed their infants and meet their nutritional needs. In this method, handling and preparation of fortifiers is easy. According to the study conducted by Nestle Nutritional Institute, more than 67% of infants accepted devices and fortifiers during nursing. Further, efforts are being made to develop ready-to-use, liquid human milk fortifier mixtures that can be directly fed during breast feeding.

Thus, the new ways of feeding fortifiers are expected to introduce new trends into the Europe human milk fortifier market during the forecast period.

On the contrary, lack of awareness among parents and caregivers hurdles the growth of Europe human milk fortifier market. 

Based on form, the Europe human milk fortifier market is bifurcated into powder and liquid. The powder segment held 60.5% market share in 2023, amassing US$ 49.98 million. It is projected to garner US$ 92.76 million by 2030 to expand at 9.2% CAGR during 2023–2030.

Based on distribution channel, the Europe human milk fortifier market is bifurcated into online and offline. The offline segment held 78.0% market share in 2023, amassing US$ 64.46 million. It is projected to garner US$ 117.33 million by 2030 to expand at 8.9% CAGR during 2023–2030.

Based on country, the Europe human milk fortifier market has been categorized into Germany, France, Italy, Russia, the UK, and the Rest of Europe.  Our regional analysis states that the Rest of Europe captured 27.9% share of Europe human milk fortifier market in 2023. It was assessed at US$ 23.07 million in 2023 and is likely to hit US$ 44.88 million by 2030, exhibiting a CAGR of 10.0% during 2023–2030.            

Key players operating in the Europe human milk fortifier market are Abbott Laboratories, Nestle SA, Prolacta Bioscience Inc, Raptakos, Brett & Co Ltd, NeoKare Nutrition Ltd, Danone SA, Neolac Inc, and Reckitt Benckiser Group Plc, among others.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com